| Dr Eric Robin Goldberg, DO | |
|
421 Cottage Grove Rd, Suite B, Bloomfield, CT 06002-3119 | |
| (860) 242-3933 | |
| (860) 242-3301 |
| Full Name | Dr Eric Robin Goldberg |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 421 Cottage Grove Rd, Bloomfield, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245226406 | NPI | - | NPPES |
| 001002469 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 000246 (Connecticut) | Primary |
| 207Q00000X | Family Medicine | 000246 (Connecticut) | Secondary |
| Entity Name | Charter Oak Health Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992750855 PECOS PAC ID: 3870401078 Enrollment ID: O20040220000909 |
News Archive
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother has been found by a team of UK scientists. The results of their study - which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma - are published online (10 November) in the Journal of Allergy and Clinical Immunology.
Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.
"[T]he House Foreign Affairs Committee (HFAC) [on Wednesday] approved the FY 2013 Foreign Relations Authorization Act [.pdf] that it hopes will be the first authorizing bill to pass Congress in a decade," Casey Dunning of the Center for Global Development (CGD) writes in this post in the center's "Rethinking U.S. Foreign Assistance" blog.
› Verified 8 days ago
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851571608 PECOS PAC ID: 9739260019 Enrollment ID: O20110707000087 |
News Archive
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother has been found by a team of UK scientists. The results of their study - which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma - are published online (10 November) in the Journal of Allergy and Clinical Immunology.
Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.
"[T]he House Foreign Affairs Committee (HFAC) [on Wednesday] approved the FY 2013 Foreign Relations Authorization Act [.pdf] that it hopes will be the first authorizing bill to pass Congress in a decade," Casey Dunning of the Center for Global Development (CGD) writes in this post in the center's "Rethinking U.S. Foreign Assistance" blog.
› Verified 8 days ago
| Entity Name | Westport Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154672483 PECOS PAC ID: 4688826712 Enrollment ID: O20121218000225 |
News Archive
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother has been found by a team of UK scientists. The results of their study - which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma - are published online (10 November) in the Journal of Allergy and Clinical Immunology.
Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.
"[T]he House Foreign Affairs Committee (HFAC) [on Wednesday] approved the FY 2013 Foreign Relations Authorization Act [.pdf] that it hopes will be the first authorizing bill to pass Congress in a decade," Casey Dunning of the Center for Global Development (CGD) writes in this post in the center's "Rethinking U.S. Foreign Assistance" blog.
› Verified 8 days ago
| Entity Name | Afc Physicians Of Connecticut, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003152984 PECOS PAC ID: 5193966893 Enrollment ID: O20130723000274 |
News Archive
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother has been found by a team of UK scientists. The results of their study - which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma - are published online (10 November) in the Journal of Allergy and Clinical Immunology.
Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.
"[T]he House Foreign Affairs Committee (HFAC) [on Wednesday] approved the FY 2013 Foreign Relations Authorization Act [.pdf] that it hopes will be the first authorizing bill to pass Congress in a decade," Casey Dunning of the Center for Global Development (CGD) writes in this post in the center's "Rethinking U.S. Foreign Assistance" blog.
› Verified 8 days ago
| Entity Name | Connecticut Urgent Care Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295151934 PECOS PAC ID: 6507180577 Enrollment ID: O20150122000355 |
News Archive
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother has been found by a team of UK scientists. The results of their study - which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma - are published online (10 November) in the Journal of Allergy and Clinical Immunology.
Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.
"[T]he House Foreign Affairs Committee (HFAC) [on Wednesday] approved the FY 2013 Foreign Relations Authorization Act [.pdf] that it hopes will be the first authorizing bill to pass Congress in a decade," Casey Dunning of the Center for Global Development (CGD) writes in this post in the center's "Rethinking U.S. Foreign Assistance" blog.
› Verified 8 days ago
| Entity Name | Excel Urgent Care Of Stamford Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306243571 PECOS PAC ID: 6103140181 Enrollment ID: O20150122000551 |
News Archive
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother has been found by a team of UK scientists. The results of their study - which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma - are published online (10 November) in the Journal of Allergy and Clinical Immunology.
Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.
"[T]he House Foreign Affairs Committee (HFAC) [on Wednesday] approved the FY 2013 Foreign Relations Authorization Act [.pdf] that it hopes will be the first authorizing bill to pass Congress in a decade," Casey Dunning of the Center for Global Development (CGD) writes in this post in the center's "Rethinking U.S. Foreign Assistance" blog.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Robin Goldberg, DO 421 Cottage Grove Rd, Suite B, Bloomfield, CT 06002-3119 Ph: (860) 242-3933 | Dr Eric Robin Goldberg, DO 421 Cottage Grove Rd, Suite B, Bloomfield, CT 06002-3119 Ph: (860) 242-3933 |
News Archive
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new indication comes just six weeks following the October 16th approval of Eylea for the treatment of visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO).
Evidence suggesting that the risk of childhood asthma associated with prenatal paracetamol exposure may depend on antioxidant genes in the mother has been found by a team of UK scientists. The results of their study - which strengthens the argument for a causal link between paracetamol exposure in early life and later childhood asthma - are published online (10 November) in the Journal of Allergy and Clinical Immunology.
Alexandros Tzatsos, M.D., Ph.D., assistant professor of anatomy and regenerative biology at the George Washington University School of Medicine and Health Sciences, was awarded over one million dollars in grants from the National Institutes of Health to study the molecular foundations of pancreatic cancer.
"[T]he House Foreign Affairs Committee (HFAC) [on Wednesday] approved the FY 2013 Foreign Relations Authorization Act [.pdf] that it hopes will be the first authorizing bill to pass Congress in a decade," Casey Dunning of the Center for Global Development (CGD) writes in this post in the center's "Rethinking U.S. Foreign Assistance" blog.
› Verified 8 days ago
Richard Siahaan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 421 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-0034 Fax: 860-242-3301 | |
Tracy E Patel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-242-3052 | |
Dr. Roy A Kellerman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 35 Jolley Dr Ste 201, Bloomfield, CT 06002 Phone: 860-243-5569 Fax: 860-243-2622 | |
Arthur Bernard Landry Jr., M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 711 Cottage Grove Rd, Cottage Grove Cardiology, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-769-5009 | |
Dr. Linda Rickman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 852 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-714-5895 Fax: 860-714-5417 | |
Oksana Kloyzner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Cottage Grove Rd, Suite F, Bloomfield, CT 06002 Phone: 860-242-4000 Fax: 860-243-8286 | |
Usama Bin Nasir, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-8756 |